Author + information
- Ashwin Nathan,
- Sameed Ahmed Khatana,
- Robert Yeh,
- Peter Groeneveld and
- Jay Giri
Percutaneous coronary intervention (PCI) is the treatment of choice for acute myocardial infarction (AMI). In New York state (NY), there has been public reporting and ranking of hospital PCI mortality for decades, but only more recently, has there been public reporting and ranking of hospital outcomes after AMI. We seek to identify the relationship between publicly reported hospital-specific disease mortality for AMI and hospital-specific procedural mortality for Emergency PCI in NY.
Publicly available outcomes of Emergency PCI between 2013-2015 and AMI in 2015 were used for all participating hospitals in NY that performed PCI from the NY Department of Health website. Emergency PCI is defined by patients with hemodynamic instability or with an AMI within the preceding 24 hours. Risk-standardized mortality rates (RSMR) were determined based on available risk-adjusted mortality rates and hospital case volumes. A Spearman's rank correlation coefficient was calculated for hospital specific AMI RSMR and Emergency PCI RSMR.
There were 62 hospitals included in the analysis. There was no difference in AMI RSMR when comparing hospitals in the top quartile of Emergency PCI RSMR to hospitals in the bottom quartile of Emergency PCI RSMR (8.31 (SD 0.40) vs. 8.49 (SD 0.38), p=0.20). Spearman's rank correlation coefficient between RSMR for PCI and RSMR for AMI produced a rho of 0.24 (p=0.237)
At the individual hospital level, there is a poor correlation between hospital performance for PCI and AMI in NY. These findings suggest that the collection of data using common existing outcomes metrics for PCI do not reflect the overall quality of cardiovascular care provided by individual hospitals after AMI.
Poster Hall, Hall F
Saturday, March 16, 2019, 10:00 a.m.-10:45 a.m.
Session Title: Interventional Cardiology: ACS/AMI/Hemodynamics and Pharmacology 1
Abstract Category: 15. Interventional Cardiology: ACS/AMI/Hemodynamics and Pharmacology
Presentation Number: 1102-023
- 2019 American College of Cardiology Foundation